<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910515-0026</DOCNO><DOCID>910515-0026.</DOCID><HL>   Ex-Official of Amgen   Sues Others, Charging   Insider Stock Trading</HL><DATE>05/15/91</DATE><SO>WALL STREET JOURNAL (J), NO PAGE CITATION</SO><CO>   AMGN</CO><MS>FINANCIAL (FIN)TECHNOLOGY (TEC)</MS><IN>MEDICAL AND BIOTECHNOLOGY, GENETIC RESEARCH, PROSTHETICS (MTC)SECURITIES (SCR)STOCK MARKET, OFFERINGS (STK)</IN><NS>STOCK andamp; OTHER MARKET NEWS (STK)</NS><RE>CALIFORNIA (CA)</RE><LP>   VENTURA, Calif. -- A former Amgen Inc. contractsadministrator filed a lawsuit against several top executivesof the biotechnology concern charging them with insider stocktrading.   The suit, filed by Benjamin Y. Mahler in Ventura CountySuperior Court, charged that former Amgen President Harry F.Hixson Jr. and two other company officers &quot;publicly tradedAmgen stock based on insider information as to when the Foodand Drug Administration would approve&quot; Amgen's products.</LP><TEXT>   As a result of the alleged insider trading, Mr. Hixson andthe other executives &quot;earned substantial illegal profits,&quot;the suit charged.   An attorney for Amgen, based in Thousand Oaks, Calif.,said: &quot;We have no reason to believe there was any improperinside trading by any Amgen executive.&quot; He added that thereisn't any Securities and Exchange Commission investigationgoing on -- and &quot;none is called for. &quot; Mr. Hixson and theother executives couldn't be reached for comment. Mr. Hixsonresigned as Amgen president and chief executive officer lastFebruary.   The Amgen attorney said the suit was filed by a&quot;disgruntled terminated employee.&quot;   According to the suit, Mr. Mahler was wrongfullyterminated in June 1990, and one of the reasons was hisrefusal to participate in the alleged insider tradingconspiracy. The suit seeks $10 million in punitive damagesfrom each of the defendants, as well as compensation foremotional distress, loss of income and loss of benefits.</TEXT></DOC>